首页>
外国专利>
NON-PEGYLATED LIPOSOMAL DOXORUBICIN COMBINATIONS FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
NON-PEGYLATED LIPOSOMAL DOXORUBICIN COMBINATIONS FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
展开▼
机译:非聚乙二醇脂质体阿霉素联合治疗三阴性乳腺癌
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a method for treating triple-negative metastatic breast cancer in an individual comprising administering to an individual in need thereof a dosing regimen which comprises nonpegylated liposomal doxorubicin, a taxane and a chemotherapeutic agent selected from the group consisting of capecitabine, vinorelbine, gemcitahine, carboplatin, and ixahepilone, and wherein said individual previously has been administered an anthracycline. In some embodiments, the individual is not administered transtuzumab.
展开▼